Skip to content

Abstract B016: MHC-II expressing pancreatic tumor cells alter macrophage polarization through VEGFA-NRP1 signaling

Sep 2026 · Cancer Research · 0 citations

TL;DR

Findings suggest VEGFA–NRP1 signaling drives immune evasion in PDAC and identifies a therapeutic axis for reprogramming TAMs, providing a foundation for future combination immunotherapy strategies.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy characterized by an immunosuppressive tumor microenvironment (TME) that limits the efficacy of immunotherapies. Tumor-associated macrophages (TAMs) represent a major cellular component of the TME and play a critical role in sustaining immunosuppressive signaling within the tumor. We aim to define the molecular mechanisms and signaling directionality between TAMs and tumor cells to test whether disrupting these pathways can reprogram TAMs to support antitumor immunity. To assess the impact of tumor-intrinsic inflammatory programs on TAM behavior, 9 patient-derived PDAC organoid (PDO) models were analyzed. PDOs were generated from surgical specimens by mechanical and enzymatic dissociation to isolate tumor epithelial cells. Spatial proteomic profiling of 15 PDAC patient samples was performed using imaging mass cytometry to identify proximal cellular populations. In addition, single-cell RNA-sequencing data from 172 human PDAC tumors were analyzed using DominoSignal to infer intercellular crosstalk. This comparison aimed to define how inducible MHC class II (MHC-II) expression on tumor cells shapes TAM phenotypes and to identify the ligand–receptor interactions that govern TAM–tumor communication. PDO cultures stimulated with IFN-γ exhibited robust induction of MHC-II, indicating an inflammatory, antigen-presenting tumor cell state. Spatial profiling of human PDAC tissues demonstrated that MHC-II expressing tumor cells localize closer to macrophages than MHC-II negative tumor cells, suggesting tumor - TAM crosstalk. Single cell transcriptomic analysis identified heterogeneous TAM subsets and demonstrated that MHC-II expressing tumor cells exhibited increased outgoing signaling toward all TAM populations. Among these interactions, VEGFA was downregulated in MHC-II expressing tumor cells, with its receptor NRP1 being enriched on TAMs, implicating this axis in maintenance of an anti-inflammatory TAM phenotype. These findings suggest VEGFA–NRP1 signaling drives immune evasion in PDAC and identifies a therapeutic axis for reprogramming TAMs, providing a foundation for future combination immunotherapy strategies. Tamara Lopez-Vidal, Jacob Mitchell, Kylie Belanger, Richard A. Burkhart, Elana J. Fertig, Won Jin Ho, Jacquelyn W. Zimmerman. MHC-II expressing pancreatic tumor cells alter macrophage polarization through VEGFA-NRP1 signaling [abstract]. In: Proceedings of the AACR Conference on Pancreatic Cancer: New Frontiers in Biology and Therapeutic Development; 2026 Sep 25-28; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(18_Suppl_2):Abstract nr B016.

View source

Similar papers

Sep 2026

Abstract B101: Stroma-tumor crosstalk converges with oncogenic KRAS signaling to drive an NFκB-mediated immune evasion program

An immunosuppressive tumor microenvironment (TME) is a hallmark of pancreatic ductal adenocarcinoma (PDAC), rendering most tumors resistant to immunotherapy approaches. Importantly, “tumor-to-stroma” crosstalk downstream of oncogenic KRAS has emerged as a major driver of immune evasion in PDAC, however the role of re...

Yuwenbin Li, Morgan L. Truitt, Dan Cao et al. · 0 citations
Sep 2026

Abstract B083: Mutant KRAS cooperates with the hypoxic tumor microenvironment to drive immunosuppressive macrophages via a paracrine PGE2/GM-CSF axis

Hypoxia is known to drive an immunosuppressive microenvironment in pancreatic ductal adenocarcinoma (PDAC). However, the underlying immunosuppressive mechanisms remain unclear. Here, we hypothesized that hypoxia-induced factors secreted from tumor cells promoted immunosuppressive macrophages in PDAC. We tr...

Matthew T. Cribb, Ayeisha N. Colón-Ortiz, Sahar Fattani et al. · 0 citations
Open access Sep 2026

IFNγ-dependent tumor-cell MHC-II is restrained by MAPK signaling and associated with immunotherapy responsiveness in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is characterized by an immunosuppressive tumor microenvironment (TME) and poor prognosis. Although major histocompatibility complex class II (MHC-II) is typically expressed by professional antigen-presenting cells, its regulation and significance in malignant PDAC cells remain un...

Can-Ping Chen, Yi Zhang, Xi Li et al. · 0 citations
Sep 2026

Abstract A002: Transcriptional regulation and membrane sequestration of myeloid-derived TNF in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy defined by stromal desmoplasia, inflammation, and an immunosuppressive tumor microenvironment (TME) enriched for innate immune cells and characterized by effector T-cell dysfunction. Beyond malignant epithelial cells, the PDAC TME is composed predominantl...

Andrew Adams, H. Amirian, C. Rafie et al. · 0 citations
Open access Aug 2026

Molecular mechanisms by which tumor cell CD73-mediated adenosine signaling drives M2 polarization of macrophages in non-small cell lung cancer

Background Immune checkpoint inhibitors have improved outcomes for a subset of patients with non-small cell lung cancer (NSCLC), but the immunosuppressive tumor microenvironment (TME) limits their efficacy. Polarization of tumor-associated macrophages (TAMs) toward an M2 phenotype is a key feature of immune escape in N...

Q. Zheng, Binbing Qin, Bin Shen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.